ES
Evan Seigerman BMO Capital Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
36
Avg Return
Past Year
Past Year
4.7%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
73%
Neutral
21.6%
Negative
5.4%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Outperform
Upgraded
| $130 |
18%
upside
| 2 | +11% |
0
%
| 18 Dec ‘25 21 days ago |
|
|
|
Outperform
Maintained
| $54 |
42%
upside
| 3 | +45% |
0
%
| 9 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $850 |
5%
upside
| 4 | +11% |
0
%
| 4 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $1,200 |
10%
upside
| 2 | +8.7% |
0
%
| 4 Dec ‘25 1 month ago |
|
|
|
Outperform
Maintained
| $372 |
12%
upside
| 2 | +9.4% |
0
%
| 3 Dec ‘25 1 month ago |
|
|
|
Market Perform
Maintained
| $46 |
20%
downside
| 3 | -26% |
–
| 25 Nov ‘25 1 month ago |
|
|
|
Market Perform
Upgraded
| $11 |
31%
upside
| 3 | -161% |
0
%
| 3 Nov ‘25 2 months ago |
|
|
|
Outperform
Maintained
| $240 |
7%
upside
| 2 | +11% |
0
%
| 12 Sep ‘25 3 months ago |
|
|
|
Outperform
Maintained
| $530 |
12%
upside
| 2 | +4.4% |
0
%
| 5 Aug ‘25 5 months ago |
|
|
|
Underperform
Maintained
| $60 |
44%
downside
| 1 | -38% |
0
%
| 30 Jul ‘25 5 months ago |
|
|
|
Outperform
Maintained
| $26 |
37%
upside
| 2 | -1.1% |
0
%
| 12 Jun ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $110 | – | 1 | +133% |
0
%
| 23 May ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $28 |
5%
upside
| 2 | +37% |
0
%
| 19 May ‘25 7 months ago |
|
|
|
Outperform
Maintained
| $120 |
52%
upside
| 1 | +79% |
0
%
| 12 May ‘25 8 months ago |
|
|
|
Market Perform
Maintained
| $115 |
16%
downside
| 1 | – |
–
| 6 May ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $10 |
19%
downside
| 1 | +59% |
0
%
| 5 May ‘25 8 months ago |
|
|
|
Outperform
Maintained
| $120 |
1%
downside
| 3 | +9% |
0
%
| 17 Apr ‘25 8 months ago |
|
|
|
Market Perform
Maintained
| $139 |
25%
downside
| 2 | -22% |
–
| 13 Feb ‘25 10 months ago |
|